Moderna Inc. (MRNA) Q4 2025 (USD): EPS -2.11 (exp. -2.54), Revenue 700mln (exp. 635mln)

Moderna's Q4 2025 results beat expectations on both EPS and revenue, which indicates a stronger operational performance than analysts anticipated.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

BoE Chief Economist Pill says process of disinflation is intact, it is not complete; need to maintain monetary policy restrictiveness

Ukraine President Zelensky says Ukraine plans to open 10 joint drone production facilities this year; he visited joint Ukrainian-German drone production

Moderna Inc. (MRNA) Q4 2025 (USD): EPS -2.11 (exp. -2.54), Revenue 700mln (exp. 635mln)

Moderna Inc. (MRNA) - Q4 2025 (USD): Revenue 678mln (exp. 635mln), EPS -2.11 (exp. -2.54)

Russia's Foreign Minister Lavrov held a phone call with his Saudi counterpart, TASS reports; talks were focused on Iran and Gaza

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This positive surprise could imply a more favorable outlook for the company's future growth, enhancing investor sentiment and potentially lifting share prices in the biotechnology sector.

Related headlines

The whole workspace, free to try.

Try it free